コンテンツへスキップ
Merck
  • Bioenergetic consequences from xenotopic expression of a tunicate AOX in mouse mitochondria: Switch from RET and ROS to FET.

Bioenergetic consequences from xenotopic expression of a tunicate AOX in mouse mitochondria: Switch from RET and ROS to FET.

Biochimica et biophysica acta. Bioenergetics (2019-12-12)
Marten Szibor, Timur Gainutdinov, Erika Fernandez-Vizarra, Eric Dufour, Zemfira Gizatullina, Grazyna Debska-Vielhaber, Juliana Heidler, Ilka Wittig, Carlo Viscomi, Frank Gellerich, Anthony L Moore
要旨

Electron transfer from all respiratory chain dehydrogenases of the electron transport chain (ETC) converges at the level of the quinone (Q) pool. The Q redox state is thus a function of electron input (reduction) and output (oxidation) and closely reflects the mitochondrial respiratory state. Disruption of electron flux at the level of the cytochrome bc1 complex (cIII) or cytochrome c oxidase (cIV) shifts the Q redox poise to a more reduced state which is generally sensed as respiratory stress. To cope with respiratory stress, many species, but not insects and vertebrates, express alternative oxidase (AOX) which acts as an electron sink for reduced Q and by-passes cIII and cIV. Here, we used Ciona intestinalis AOX xenotopically expressed in mouse mitochondria to study how respiratory states impact the Q poise and how AOX may be used to restore respiration. Particularly interesting is our finding that electron input through succinate dehydrogenase (cII), but not NADH:ubiquinone oxidoreductase (cI), reduces the Q pool almost entirely (>90%) irrespective of the respiratory state. AOX enhances the forward electron transport (FET) from cII thereby decreasing reverse electron transport (RET) and ROS specifically when non-phosphorylating. AOX is not engaged with cI substrates, however, unless a respiratory inhibitor is added. This sheds new light on Q poise signaling, the biological role of cII which enigmatically is the only ETC complex absent from respiratory supercomplexes but yet participates in the tricarboxylic acid (TCA) cycle. Finally, we delineate potential risks and benefits arising from therapeutic AOX transfer.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
MOPS, ≥99.5% (titration)
Sigma-Aldrich
スクロース, ≥99.5% (GC), BioXtra
Sigma-Aldrich
アデノシン 5′-二リン酸 ナトリウム塩, bacterial, ≥95% (HPLC)
Sigma-Aldrich
アンチマイシンA 放線菌由来
Sigma-Aldrich
ピルビン酸ナトリウム, powder, BioReagent, suitable for cell culture, suitable for insect cell culture, ≥99%
Sigma-Aldrich
ロテノン, ≥95%
Sigma-Aldrich
カルボニルシアニド 4-(トリフルオロメトキシ)フェニルヒドラゾン, ≥98% (TLC), powder
Sigma-Aldrich
ペルオキシダーゼ from horseradish, Type II, essentially salt-free, lyophilized powder, 150-250 units/mg solid (using pyrogallol)
Sigma-Aldrich
オリゴマイシン Streptomyces diastatochromogenes由来, ≥90% total oligomycins basis (HPLC)
Sigma-Aldrich
DL-ジチオトレイトール, ≥99.0% (RT)
Sigma-Aldrich
抗ウサギIgG (全分子)-ペルオキシダーゼ ヤギ宿主抗体, affinity isolated antibody
Sigma-Aldrich
没食子酸プロピル, powder
Sigma-Aldrich
L-グルタミン酸 一ナトリウム塩 一水和物, ≥98.0% (NT)
Sigma-Aldrich
細菌プロテイナーゼ, Type XXIV, 7.0-14.0 units/mg solid, lyophilized powder
Sigma-Aldrich
L-(−)-リンゴ酸, ≥95% (titration)
Sigma-Aldrich
アジ化ナトリウム, ReagentPlus®, ≥99.5%
Sigma-Aldrich
D-マンニトール, ≥98% (GC)
Sigma-Aldrich
エチレングリコール-ビス(2-アミノエチルエーテル)-N,N,N′,N′-四酢酸, ≥97.0%
Sigma-Aldrich
コハク酸ナトリウム 二塩基性 六水和物, ReagentPlus®, ≥99%
Sigma-Aldrich
アデノシン 5′-二リン酸, ≥95% (HPLC)
Sigma-Aldrich
サフラニンO, Dye content ≥85 %
Sigma-Aldrich
スーパーオキシドジスムターゼ ウシ肝臓由来, ammonium sulfate suspension, 2,000-6,000 units/mg protein (biuret)
Supelco
[(3R)-3-Hydroxytetradecanoyl]-L-carnitine, analytical standard